Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.71 |
| ▸ | ABCB1 | P08183 | 1/20 | 0.40 |
| ▸ | POLB | P06746 | 1/20 | 0.40 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL426635 | 1.00 | TDP1 (0.71) | TDP1ABCB1POLBMAPK1 | |
| SCHEMBL15653578 | 1.00 | TDP1 (0.71) | TDP1ABCB1POLBMAPK1 | |
| SCHEMBL15484170 | 1.00 | TDP1 (0.71) | TDP1ABCB1POLBMAPK1 | |
| SCHEMBL29529175 | 1.00 | TDP1 (0.71) | TDP1ABCB1POLBMAPK1 | |
| SCHEMBL60713 | 1.00 | TDP1 (0.71) | TDP1ABCB1POLBMAPK1 | |
| SCHEMBL421756 | 1.00 | TDP1 (0.71) | TDP1ABCB1POLBMAPK1 | |
| Potassium SCHEMBL30587676 | 0.98 | TDP1 (0.69) | TDP1ABCB1POLBMAPK1 | |
| Hydrochloric Acid SCHEMBL30259230 | 0.98 | TDP1 (0.69) | TDP1ABCB1POLBMAPK1 | |
| SCHEMBL8587285 | 0.95 | TDP1 (0.68) | TDP1ABCB1POLBMAPK1 | |
| SCHEMBL2279600 | 0.95 | TDP1 (0.68) | TDP1ABCB1POLBMAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114867447-A | Multilayer dissolvable solid article comprising solid particles for making multilayer dissolvable solid article | 宝洁公司 | 2022-08-05 | — | — | CN | claimed |
| US-10640526-B2 | Method of preparation of 6-azido-2,4-diacetamido-2,4,6-trideoxy-D-mannose | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) | 2020-05-05 | — | — | US | claimed |
| CN-108435107-A | A kind of preparation and its application of DNA compatibilities nanoparticle | 嘉兴杰赛生物科技有限公司 | 2018-08-24 | — | — | CN | claimed |
| WO-2026047128-A1 | A METHOD FOR N-,O-SULFONATION AND ACETYLATION OF A COMPOUND | ORGANES TISSUS REGENERATION REPARATION REMPLACEMENT (FR) | 2026-03-05 | — | — | WO | disclosed |
| CN-119455013-A | Targeting drug delivery carrier based on mesoporous polydopamine nano particles and application | 广州贝奥吉因生物科技股份有限公司 | 2025-02-18 | — | — | CN | disclosed |
| CN-119451972-A | Modified sophorolipids with enhanced defoaming properties | 轨迹方案IPCO有限责任公司 | 2025-02-14 | — | — | CN | disclosed |
| CN-119193249-A | Detergent composition and method for cleaning surface | 埃科莱布美国股份有限公司 | 2024-12-27 | — | — | CN | disclosed |
| CN-114867447-B | Multilayer soluble solid article comprising solid particles for preparing multilayer soluble solid article | 宝洁公司 | 2024-11-29 | — | — | CN | disclosed |
| CN-110526950-B | Preparation method of alpha-five-O-acetyl mannose | 济南山目生物医药科技有限公司 | 2023-08-04 | — | — | CN | disclosed |
| CN-115066483-A | Water soluble unit dose articles | 宝洁公司 | 2022-09-16 | — | — | CN | disclosed |
| CN-114981397-A | Water soluble unit dose articles | 宝洁公司 | 2022-08-30 | — | — | CN | disclosed |
| CN-107000383-A | Multiple layer interlayers of polyvinyl acetal and cellulose ester | 首诺公司 | 2017-08-01 | — | — | CN | disclosed |
| CN-102762528-B | Low Viscosity Liquid Crystal Compounds | CYTOPATHFINDER INC | 2015-07-08 | — | — | CN | disclosed |
| CN-104519889-A | Use of a glycosylated-modified tetrafunctional non-ionic amphiphilic block copolymer as immune adjuvant | INST NAT SANTE RECH MED | 2015-04-15 | — | — | CN | disclosed |
| US-8540966-B2 | Contrast agents endowed with high relaxivity | BRACCO IMAGING S.P.A. (IT) | 2013-09-24 | — | — | US | disclosed |
| US-20110256067-A1 | Contrast agents endowed with high relaxivity | BRACCO IMAGING SPA (IT) | 2011-10-20 | — | — | US | disclosed |
| US-7988950-B2 | Contrast agents endowed with high relaxivity for use in magnetic resonance imaging (MRI) which contain a chelating moiety with polyhydroxylated substituents | BRACCO IMAGING S.P.A. (IT) | 2011-08-02 | — | — | US | disclosed |
| EP-1765812-B1 | CONTRAST AGENTS ENDOWED WITH HIGH RELAXIVITY FOR USE IN MAGNETIC RESONANCE IMAGING (MRI) WHICH CONTAIN A CHELATING MOIETY WITH POLYHYDROXYLATED SUBSTITUENTS | BRACCO IMAGING SPA (IT) | 2009-04-29 | — | — | EP | disclosed |
| EP-1786475-B1 | 1,4-BIS(CARBOXYMETHYL)-6-[BIS(CARBOXYMETHYL)AMINO]-6-METHYL-PERHYDRO-1,4-DIAZEPINE (AAZTA) DERIVATIVES AS LIGANDS IN HIGH RELAXIVITY CONTRAST AGENTS FOR USE IN MAGNETIC RESONANCE IMAGING (MRI) | BRACCO IMAGING SPA (IT) | 2009-04-29 | — | — | EP | disclosed |
| US-20070258905-A1 | Contrast Agents Endowed with High Relaxivity for Use in Magnetic Resonance Imaging (Mri) Which Contain a Chelating Moiety with Polyhydroxylated Substituents | BRACCO IMAGING SPA (IT) | 2007-11-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110256067-A1 | Contrast agents endowed with high relaxivity | SLC40A1, SLC67A1, SLC19A1 | TDP1 1664/4885ABCB1 1017/4885POLB 2289/4885 |
| US-10640526-B2 | Method of preparation of 6-azido-2,4-diacetamido-2,4,6-trideoxy-D-mannose | ST6GAL1, B4GALT1, GALNT6 | TDP1 2029/4885ABCB1 4158/4885POLB 2482/4885 |
| US-20070258905-A1 | Contrast Agents Endowed with High Relaxivity for Use in Magnetic Resonance Imaging (Mri) Which Contain a Chelating Moiety with Polyhydroxylated Substituents | RXFP1, SLC5A7, SLC40A1 | TDP1 1659/4885ABCB1 2529/4885POLB 3892/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.